Abstract
Target therapy for driver gene-positive cases is one of the standard treatments in advanced or recurrent non-small cell lung cancer (NSCLC). However, there is a need for a simple method to find rare driver genes due to their rarity. We developed and evaluated the algorithm to detect rare driver gene in NSCLC comprehensively using pathological images and AI.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
